WHO ICTRP trial
The effects of allogeneic blood infusion on postoperative cognitive dysfuntion…
ChiCTR-IOC-17013876 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IOC-17013876 |
|---|---|
| Public title | The effects of allogeneic blood infusion on postoperative cognitive dysfuntion in aged patients |
| Scientific title | The effects of allogeneic blood infusion on postoperative cognitive dysfuntion in aged patients |
| Primary sponsor | the Third Hospital of Hebei Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Conditions | ola-age |
| Interventions | Control group:Standard treatment;allogeneic blood group:allogeneic plasma treament |
| Registration date | Dec 12, 2017 |
| Target size | Control group:50;allogeneic blood group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: